Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yingyu Qi"'
Autor:
Xiaomeng Yang, Yajiao Cui, Yingyu Qi, Luyan Fu, Armin Rezayan, Chunbao Charles Xu, Jianshe Wang, Dong Sui, Yongsheng Zhang
Publikováno v:
Journal of Alloys and Compounds. 958:170513
Autor:
Yingyu Qi
Publikováno v:
Applied Mathematics and Computation. 417:126776
In this study, we propose a multi-stencils fast marching method to solve the factored eikonal equations for media with quadratic anisotropy, also known as Riemannian anisotropy. Compared with the conventional fast marching method, the new method has
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background Acute myeloid leukemia (AML) showed limited clinical therapeutic efficiency with chemotherapy for its multi-distributed lesions and hard-to-kill leukemia cells deep in the bone marrow. Results Here, a biomimetic nanosystem (DR@PLi
Externí odkaz:
https://doaj.org/article/6e7fc251ac954af7af720a8ddbd1f20f
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
CD8+ T cells belonging to the adaptive immune system play key roles in defending against viral infections and cancers. The current CD8+ T cell-based immunotherapy has emerged as a superior therapeutic avenue for the eradication of tumor cells and lon
Externí odkaz:
https://doaj.org/article/e9d3c11d7f524bae82f58cda2be3ac1f
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
T-lymphocytes play crucial roles for maintaining immune homeostasis by fighting against various pathogenic microorganisms and establishing self-antigen tolerance. They will go through several stages and checkpoints in the thymus from progenitors to m
Externí odkaz:
https://doaj.org/article/52dbe1a9161f448f89d4fcd79fd67c39
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Memory CD8+ T cells have long been considered a promising population for adoptive cell therapy (ACT) due to their long-term persistence and robust re-stimulatory response. NIH3T3 is an immortalized mouse embryonic fibroblast cell line. We report that
Externí odkaz:
https://doaj.org/article/664779276d6e4a42848b2500b486e308
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Adoptive CD8+ T cell therapy has emerged as an important modality for the treatment of cancers. However, the significant drawback of transfused T cells is their poor survival and functionality in response to tumors. To overcome this limitation, an im
Externí odkaz:
https://doaj.org/article/ddd9376ca0dc46b49b6b2adc401b0e63